Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-37.93	36.84	59.35
Graham Fair Price	34.63	4.43	3.29
PEG	-74.73	0.14	-0.56
Price/Book	-2.36	1.14	1.17
Price/Cash Flow	61.84	108.94	67.31
Prices/Earnings	-44.00	11.02	19.67
Price/Sales	-4.92	4.69	4.93
Price/FCF	61.84	108.94	67.31
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.16	0.26	0.23
Operating Margin	101.29	0.13	0.06
ROA	77.22	0.02	< 0.005
ROE	0.01	0.03	74.36
ROIC	0.01	0.02	83.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	0.23	-86.31
Dividends QOQ	0.22	-0.09	-57.75
EBIT QOQ	-0.43	1.12	160.53
EPS QOQ	-0.35	0.78	121.58
FCF QOQ	0.02	-0.38	2412.91
Revenue QOQ	0.28	0.05	-80.33
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.47	109.00	1.42
Days Sales Outstanding (DSO)	135.71	129.25	-4.76
Inventory Turnover	0.84	0.83	-1.40
Debt/Capitalization	0.22	0.21	-4.45
Quick Ratio	1.05	1.13	7.69
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.69	5.80	1.96
Cash	0.89	0.98	10.05
Capex	-0.02	-0.03	-14.13
Free Cash Flow	0.10	0.06	-38.49
Revenue	1.35	1.41	4.70
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.50	1.61	7.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.61	4.07	-52.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating